The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
Life · 21.07.2023 · 13 (7) · 1598
DOI: 10.3390/life13071598 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.07.2023. Verfasst von João Pedro Thimotheo Batista und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130-100, MG…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Diabetic cardiomyopathy refers to myocardial dysfunction in type 2 diabetes, but without the traditional cardiovascular risk factors or overt clinical atherosclerosis and valvular disease. The activation of the renin–angiotensin system (RAS), oxidative stress, lipotoxicity, maladaptive immune responses, imbalanced mitochondrial dynamics, impaired myocyte autophagy, increased myocyte apoptosis, and fibrosis contribute to diabetic cardiomyopathy. This review summarizes the studies that address the link between cardiomyopathy and the RAS in humans and presents proposed pathophysiological mechanisms underlying this association. The RAS plays an important role in the development and progression of diabetic cardiomyopathy. The over-activation of the classical RAS axis in diabetes leads to the increased production of angiotensin (Ang) II, angiotensin type 1 receptor activation, and aldosterone release, contributing to increased oxidative stress, fibrosis, and cardiac remodeling. In contrast, Ang-(1-7) suppresses oxidative stress, inhibits tissue fibrosis, and prevents extensive cardiac remodeling. Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers improve heart functioning and reduce the occurrence of diabetic cardiomyopathy. Experimental studies also show beneficial effects for Ang-(1-7) and angiotensin-converting enzyme 2 infusion in improving heart functioning and tissue injury. Further research is necessary to fully understand the pathophysiology of diabetic cardiomyopathy and to translate experimental findings into clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil.
- Departamento de Pediatria, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil.
ORCID-Profile: Ana Cristina Simões E Silva
Förderung
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
Batista, J. P. T., Faria, A. O. V., Ribeiro, T. F. S., & Simões E Silva, A. C. (2023). The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review. Life, 13(7), 1598. https://doi.org/10.3390/life13071598
Vancouver
Batista JPT, Faria AOV, Ribeiro TFS, Simões E Silva AC. The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review. Life. 2023;13(7):1598. doi:10.3390/life13071598
BibTeX
@article{Batista2023,
author = {Batista, João Pedro Thimotheo and Faria, André Oliveira Vilela de and Ribeiro, Thomas Felipe Silva and Simões E Silva, Ana Cristina},
title = {The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review},
journal = {Life},
year = {2023},
volume = {13},
number = {7},
pages = {1598},
doi = {10.3390/life13071598}
}
EUVIMED